Insulina, che potrebbe richiedere un aggiustamento della dose e controlli pi frequenti della glicemia al fine di evitare alterazioni dei valori e la chetoacidosi diabetica (una complicazione del diabete che si verifica quando il corpo non in grado di scomporre il glucosio perch non c abbastanza insulina)
Companion to Applied Regression [R package car version 3.1-3]
Unlike SGLT2 inhibitors, semaglutide does not have diuretic properties and is not associated with increased urination as a direct side effect according to FDA prescribing information
In a separate survey by Omada Health in partnership with Sermo, more than two-thirds (67%) of primary care physicians expressed concern about patients accessing GLP-1 prescriptions for weight loss through a third-party telehealth provider, saying it may put their patients' health at risk
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes 2026 Update
If NAD+ therapy is being considered, patients should work with a qualified prescriber who can make individualised clinical judgements while acknowledging the significant evidence gaps